A comparison of technetium etidronate and pyrophosphate for acute myocardial infarct imaging.
Etidronate and pyrophosphate, labeled with Tc-95m and Tc-99m, were studied in experimentally infarcted mongrel dogs. A distribution study was conducted 2 hr after simultaneous administration of both agents in two groups of dogs. In one group, the injection was made 15 min after release of a 2-hr coronary arterial ligation. Another group was injected 48 hr after release of the ligation. The uptakes for each radiopharmaceutical and the ratio of uptakes for each sample were computed. The data show pyrophosphate to be a superior agent for the imaging of acute myocardial infarcts because of the higher uptake by infarcted myocardium and the greater contrast between infarcted myocardium and neighboring organs.
D000208:Acute Disease; D000818:Animals; D011756:Diphosphates; D004285:Dogs; D012968:Etidronic Acid; D009203:Myocardial Infarction / Q000175:diagnosis*; D011877:Radionuclide Imaging; D013667:Technetium
D011756:Diphosphates; D013667:Technetium; D012968:Etidronic Acid